Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Immunomedics Inc. IMMU

Healthcare Biotechnology
Immunomedics Inc is a clinical-stage biopharmaceutical company, based in the United States. The company develops monoclonal antibody-based products for the targeted treatment of cancer and autoimmune disorders, among others. Its portfolio of products under investigation include antibody-drug conjugates that target the tumor-reducing toxic effects of chemotherapeutic treatments. The company's... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:IMMU)

Portnoy Law Firm: Tactile Systems Technology, Inc., Pintec Technologies Holdings Limited, and Immunomedics, Inc. Investors Have Limited Amount of Time Before Class Action Deadline

GlobeNewswire November 27, 2020

Immunomedics Announces FDA Orphan Drug Designation of Trodelvy(TM) for Adult and Pediatric Glioblastoma

GlobeNewswire October 12, 2020

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Investors are Encouraged to Contact the Firm - CBMG, PTI, VRTU, IMMU

ACCESSWIRE IA October 12, 2020

STOCKHOLDER ALERT: Monteverde & Associates Reminds Investors of its Ongoing Investigation Regarding the Merger

ACCESSWIRE IA October 9, 2020

ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders are Encouraged to Contact the Firm - CBMG, VRTU, MR, IMMU, JCAP

PR Newswire October 5, 2020

WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations

PR Newswire October 2, 2020

SHAREHOLDER ALERT: Monteverde & Associates Are Investigating the Following Merger

ACCESSWIRE IA October 1, 2020

IMPORTANT SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors About Its Ongoing Investigations; Shareholders are Encouraged to Contact the Firm - CBMG, RST, IMMU, VAR

ACCESSWIRE IA September 26, 2020

WeissLaw LLP Reminds MR, IMMU, and BMCH Shareholders About Its Ongoing Investigations

PR Newswire September 25, 2020
View More News ››

Opinion & Analysis (NDAQ:IMMU)

Immunomedics Shares Double as Phase 3 Breast Cancer Trial Achieves 'Compelling' Efficacy Data

Streetwise Reports April 7, 2020

Coverage Initiated on Immunotherapy Developer with Phase 3 Lead Asset

Streetwise Reports June 20, 2018
View More Opinion ››

Bullboard Posts (NDAQ:IMMU)

Why Immunomedics, Inc. Rocketed Today

https://www.google.ca/finance?q=NASDAQ%3AIMMU&authuser=0&ei=puENWfi2NIifjAGy55joDA https://www.fool.com/investing/2017/05/05/why...
clyde - May 6, 2017

RE:RE:RE:Pretty silent crowd here

They played with it, dropped the peice way down  and then ran it back up to US$3.50.
Mexymax - November 22, 2016

RE:RE:Pretty silent crowd here

This may have bottomed and it is now moving up to the $3 level.
Mexymax - August 5, 2016

RE:Pretty silent crowd here

Pretty quite indeed since this post is almost a year since the original post.  Nice recent move in share price, anyone out there and...
kcac1 - June 8, 2015

Pretty silent crowd here

Anyone have any info at all regarding previous posters questions? best, c
chester2 - June 18, 2014

IXS combo

Can anyone tell me the status of IXS with Immunomedics, the collaborations and status of such. I can not find anything out about this...
cashin17 - May 15, 2014
View more Bullboard ››

Fobi AI Inc

Fobi AI Inc

Fobi AI Inc. is a Canada-based artificial intelligence (AI) and data intelligence company. The Company operates in the ...
View More »